Impact of Ashwagandha in Obesity Parameters from Mexican Adults

NCT ID: NCT06676605 Phase: NA Status: COMPLETED Enrollment: 34 Completion: 2024-01-30

Conditions

Obesity, Overweight

Interventions

Withania somnifera, Placebo Intervention

Summary

This clinical trial aimed to assess the impact of ashwagandha supplementation on serum lipid concentrations and body composition in Mexican adults with overweight and obesity. It was a double-blind, placebo-controlled pilot study, including adult patients who consumed ashwagandha pills for 40 days after giving informed consent. Two groups were part of the study: an experimental group receiving the supplement and a placebo group. Measurements conducted included anthropometric parameters and blood biochemical parameters.

Primary Outcome

Body Weight Measurement

Source

ClinicalTrials.gov